{
    "info": {
        "Nasdaq_Traded": "Y",
        "Symbol": "ACRX",
        "Security_Name": "AcelRx Pharmaceuticals, Inc. - Common Stock",
        "Listing_Exchange": "Q",
        "Market_Category": "G",
        "ETF": "N",
        "Round_Lot_Size": "100.0",
        "Test_Issue": "N",
        "Financial_Status": "N",
        "CQS_Symbol": "",
        "NASDAQ_Symbol": "ACRX",
        "NextShares": "N"
    },
    "history": [],
    "recommendationTrend": {
        "trend": [
            {
                "period": "0m",
                "strongBuy": 0,
                "buy": 3,
                "hold": 2,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-1m",
                "strongBuy": 0,
                "buy": 1,
                "hold": 1,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-2m",
                "strongBuy": 0,
                "buy": 1,
                "hold": 1,
                "sell": 0,
                "strongSell": 0
            },
            {
                "period": "-3m",
                "strongBuy": 1,
                "buy": 2,
                "hold": 0,
                "sell": 1,
                "strongSell": 0
            }
        ],
        "maxAge": 86400
    },
    "summaryDetail": {
        "maxAge": 1,
        "priceHint": 4,
        "previousClose": 2.28,
        "open": 2.3,
        "dayLow": 2.13,
        "dayHigh": 2.35,
        "regularMarketPreviousClose": 2.28,
        "regularMarketOpen": 2.3,
        "regularMarketDayLow": 2.13,
        "regularMarketDayHigh": 2.35,
        "payoutRatio": 0,
        "beta": 0.240301,
        "trailingPE": 0.3087819,
        "forwardPE": -0.7440273,
        "volume": 198991,
        "regularMarketVolume": 198991,
        "averageVolume": 155298,
        "averageVolume10days": 216700,
        "averageDailyVolume10Day": 216700,
        "bid": 2.12,
        "ask": 2.19,
        "bidSize": 1800,
        "askSize": 800,
        "marketCap": 17871880,
        "fiftyTwoWeekLow": 1.76,
        "fiftyTwoWeekHigh": 11.6,
        "priceToSalesTrailing12Months": 11.750086,
        "fiftyDayAverage": 2.2828,
        "twoHundredDayAverage": 4.2577,
        "trailingAnnualDividendRate": 0,
        "trailingAnnualDividendYield": 0,
        "currency": "USD",
        "fromCurrency": null,
        "toCurrency": null,
        "lastMarket": null,
        "coinMarketCapLink": null,
        "algorithm": null,
        "tradeable": false
    },
    "earnings": {
        "maxAge": 86400,
        "earningsChart": {
            "quarterly": [
                {
                    "date": "4Q2021",
                    "actual": -1.2,
                    "estimate": -1.4
                },
                {
                    "date": "1Q2022",
                    "actual": -1.2,
                    "estimate": -1.2
                },
                {
                    "date": "2Q2022",
                    "actual": 9.6,
                    "estimate": -1.5
                },
                {
                    "date": "3Q2022",
                    "actual": -0.94,
                    "estimate": -1.2
                }
            ],
            "currentQuarterEstimate": -0.51,
            "currentQuarterEstimateDate": "4Q",
            "currentQuarterEstimateYear": 2022,
            "earningsDate": [
                1678273140,
                1678708800
            ]
        },
        "financialsChart": {
            "yearly": [
                {
                    "date": 2018,
                    "revenue": 2151000,
                    "earnings": -47149000
                },
                {
                    "date": 2019,
                    "revenue": 2289000,
                    "earnings": -53240000
                },
                {
                    "date": 2020,
                    "revenue": 5416000,
                    "earnings": -40379000
                },
                {
                    "date": 2021,
                    "revenue": 2818000,
                    "earnings": -35099000
                }
            ],
            "quarterly": [
                {
                    "date": "4Q2021",
                    "revenue": 2000,
                    "earnings": -7917000
                },
                {
                    "date": "1Q2022",
                    "revenue": 442000,
                    "earnings": -8674000
                },
                {
                    "date": "2Q2022",
                    "revenue": 570000,
                    "earnings": 70663000
                },
                {
                    "date": "3Q2022",
                    "revenue": 507000,
                    "earnings": -6750000
                }
            ]
        },
        "financialCurrency": "USD"
    },
    "calendarEvents": {
        "maxAge": 1,
        "earnings": {
            "earningsDate": [
                1678273140,
                1678708800
            ],
            "earningsAverage": -0.51,
            "earningsLow": -0.92,
            "earningsHigh": -0.1,
            "revenueAverage": 4500000,
            "revenueLow": 500000,
            "revenueHigh": 8500000
        }
    },
    "upgradeDowngradeHistory": {
        "history": [
            {
                "epochGradeDate": "2022-03-14T10:23:49.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Neutral",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2021-08-17T10:22:51.000Z",
                "firm": "HC Wainwright & Co.",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2020-08-13T13:02:45.000Z",
                "firm": "Credit Suisse",
                "toGrade": "Underperform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2020-07-20T09:09:41.000Z",
                "firm": "Credit Suisse",
                "toGrade": "Underperform",
                "fromGrade": "Neutral",
                "action": "down"
            },
            {
                "epochGradeDate": "2020-03-17T12:35:59.000Z",
                "firm": "H.C. Wainwright",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2019-11-11T12:23:04.000Z",
                "firm": "Credit Suisse",
                "toGrade": "Neutral",
                "fromGrade": "Outperform",
                "action": "down"
            },
            {
                "epochGradeDate": "2019-04-24T10:30:08.000Z",
                "firm": "B. Riley FBR",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2019-02-15T13:34:08.000Z",
                "firm": "Credit Suisse",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2018-10-23T11:28:42.000Z",
                "firm": "B. Riley FBR",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2018-10-15T11:19:16.000Z",
                "firm": "Jefferies",
                "toGrade": "Buy",
                "fromGrade": "Hold",
                "action": "up"
            },
            {
                "epochGradeDate": "2018-10-10T13:59:21.000Z",
                "firm": "Ladenburg Thalmann",
                "toGrade": "Buy",
                "fromGrade": "Buy",
                "action": "reit"
            },
            {
                "epochGradeDate": "2018-08-16T12:12:06.000Z",
                "firm": "Ladenburg Thalmann",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2018-07-13T13:17:38.000Z",
                "firm": "Oppenheimer",
                "toGrade": "Perform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2018-06-12T10:33:17.000Z",
                "firm": "Cantor Fitzgerald",
                "toGrade": "Overweight",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2017-10-13T11:37:56.000Z",
                "firm": "Jefferies",
                "toGrade": "Hold",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2016-05-06T07:46:30.000Z",
                "firm": "Seaport Global",
                "toGrade": "Buy",
                "fromGrade": "Accumulate",
                "action": "up"
            },
            {
                "epochGradeDate": "2016-05-03T07:03:15.000Z",
                "firm": "H.C. Wainwright",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2015-09-02T07:07:36.000Z",
                "firm": "H.C. Wainwright",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2015-04-27T09:12:37.000Z",
                "firm": "Seaport Global",
                "toGrade": "Accumulate",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2015-03-10T10:44:49.000Z",
                "firm": "Cowen & Co.",
                "toGrade": "Market Perform",
                "fromGrade": "Outperform",
                "action": "down"
            },
            {
                "epochGradeDate": "2015-03-10T09:00:00.000Z",
                "firm": "JMP Securities",
                "toGrade": "Market Outperform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2015-03-10T08:42:36.000Z",
                "firm": "PiperJaffray",
                "toGrade": "Neutral",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2015-03-10T08:42:20.000Z",
                "firm": "RBC Capital",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2015-03-10T05:55:50.000Z",
                "firm": "Jefferies",
                "toGrade": "Hold",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2015-03-09T11:05:50.000Z",
                "firm": "Mizuho",
                "toGrade": "Neutral",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2015-02-26T04:55:18.000Z",
                "firm": "Mizuho",
                "toGrade": "Buy",
                "fromGrade": "Neutral",
                "action": "up"
            },
            {
                "epochGradeDate": "2014-11-06T05:47:40.000Z",
                "firm": "Mizuho",
                "toGrade": "Neutral",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2014-09-26T12:44:25.000Z",
                "firm": "Roth Capital",
                "toGrade": "Neutral",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2014-08-12T09:00:00.000Z",
                "firm": "Jefferies",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2014-07-29T06:17:59.000Z",
                "firm": "PiperJaffray",
                "toGrade": "Neutral",
                "fromGrade": "Overweight",
                "action": "down"
            },
            {
                "epochGradeDate": "2014-07-28T22:03:03.000Z",
                "firm": "JMP Securities",
                "toGrade": "Market Outperform",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2014-07-28T06:25:18.000Z",
                "firm": "Canaccord Genuity",
                "toGrade": "Hold",
                "fromGrade": "Buy",
                "action": "down"
            },
            {
                "epochGradeDate": "2014-04-17T07:22:05.000Z",
                "firm": "Canaccord Genuity",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2014-04-14T08:00:00.000Z",
                "firm": "Roth Capital",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2014-01-06T16:00:00.000Z",
                "firm": "RBC Capital",
                "toGrade": "Outperform",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2013-12-17T06:34:19.000Z",
                "firm": "McNicoll Lewis Vlak",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2013-08-13T06:29:00.000Z",
                "firm": "Jefferies",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2013-06-18T07:32:10.000Z",
                "firm": "Jefferies",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "main"
            },
            {
                "epochGradeDate": "2013-04-08T06:19:06.000Z",
                "firm": "Jefferies",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2013-02-04T12:47:36.000Z",
                "firm": "McNicoll Lewis Vlak",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            },
            {
                "epochGradeDate": "2013-01-29T16:39:58.000Z",
                "firm": "Mizuho",
                "toGrade": "Buy",
                "fromGrade": "",
                "action": "init"
            }
        ],
        "maxAge": 86400
    },
    "price": {
        "maxAge": 1,
        "preMarketSource": "FREE_REALTIME",
        "postMarketChangePercent": 0.0045871497,
        "postMarketChange": 0.00999999,
        "postMarketTime": "2023-01-06T22:53:07.000Z",
        "postMarketPrice": 2.19,
        "postMarketSource": "FREE_REALTIME",
        "regularMarketChangePercent": -0.043859612,
        "regularMarketChange": -0.099999905,
        "regularMarketTime": "2023-01-06T21:00:04.000Z",
        "priceHint": 4,
        "regularMarketPrice": 2.18,
        "regularMarketDayHigh": 2.35,
        "regularMarketDayLow": 2.13,
        "regularMarketVolume": 198991,
        "averageDailyVolume10Day": 216700,
        "averageDailyVolume3Month": 155298,
        "regularMarketPreviousClose": 2.28,
        "regularMarketSource": "FREE_REALTIME",
        "regularMarketOpen": 2.3,
        "exchange": "NGM",
        "exchangeName": "NasdaqGM",
        "exchangeDataDelayedBy": 0,
        "marketState": "CLOSED",
        "quoteType": "EQUITY",
        "symbol": "ACRX",
        "underlyingSymbol": null,
        "shortName": "AcelRx Pharmaceuticals, Inc.",
        "longName": "AcelRx Pharmaceuticals, Inc.",
        "currency": "USD",
        "quoteSourceName": "Nasdaq Real Time Price",
        "currencySymbol": "$",
        "fromCurrency": null,
        "toCurrency": null,
        "lastMarket": null,
        "marketCap": 17871880
    },
    "defaultKeyStatistics": {
        "maxAge": 1,
        "priceHint": 4,
        "enterpriseValue": 12879137,
        "forwardPE": -0.7440273,
        "profitMargins": 31.112429,
        "floatShares": 7360197,
        "sharesOutstanding": 8198110,
        "sharesShort": 878538,
        "sharesShortPriorMonth": 783539,
        "sharesShortPreviousMonthDate": 1668470400,
        "dateShortInterest": 1671062400,
        "sharesPercentSharesOut": 0.1179,
        "heldPercentInsiders": 0.011829999,
        "heldPercentInstitutions": 0.12358,
        "shortRatio": 5.22,
        "shortPercentOfFloat": 0.1193,
        "beta": 0.240301,
        "impliedSharesOutstanding": 0,
        "category": null,
        "bookValue": 3.676,
        "priceToBook": 0.59303594,
        "fundFamily": null,
        "legalType": null,
        "lastFiscalYearEnd": "2021-12-31T00:00:00.000Z",
        "nextFiscalYearEnd": "2023-12-31T00:00:00.000Z",
        "mostRecentQuarter": "2022-09-30T00:00:00.000Z",
        "netIncomeToCommon": 47007000,
        "trailingEps": 7.06,
        "forwardEps": -2.93,
        "lastSplitFactor": "1:20",
        "lastSplitDate": "2022-10-26T00:00:00.000Z",
        "enterpriseToRevenue": 8.468,
        "enterpriseToEbitda": -0.426,
        "52WeekChange": -0.79814816,
        "SandP52WeekChange": -0.16598755
    },
    "summaryProfile": {
        "address1": "25821 Industrial Boulevard",
        "address2": "Suite 400",
        "city": "Hayward",
        "state": "CA",
        "zip": "94545",
        "country": "United States",
        "phone": "650 216 3500",
        "website": "https://www.acelrx.com",
        "industry": "Drug Manufacturersâ€”Specialty & Generic",
        "sector": "Healthcare",
        "longBusinessSummary": "AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain; ARX-02, which is in Phase 2 clinical trial for the treatment of cancer breakthrough pain in opioid-tolerant patients; and 4ARX-03 for mild sedation and pain relief during painful procedures. Its product candidates also include Niyad, a regional anticoagulant for the extracorporeal circuit; and LTX-608, a nafamostat formulation for direct IV infusion being explored as an investigational product for antiviral treatment of COVID, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis. The company was formerly known as SuRx, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is based in Hayward, California.",
        "fullTimeEmployees": 20,
        "companyOfficers": [],
        "maxAge": 86400
    },
    "financialData": {
        "maxAge": 86400,
        "currentPrice": 2.18,
        "targetHighPrice": 80,
        "targetLowPrice": 80,
        "targetMeanPrice": 80,
        "targetMedianPrice": 80,
        "recommendationMean": 2.5,
        "recommendationKey": "buy",
        "numberOfAnalystOpinions": 1,
        "totalCash": 15926000,
        "totalCashPerShare": 2.138,
        "ebitda": -30208000,
        "totalDebt": 12474000,
        "quickRatio": 1.05,
        "currentRatio": 1.568,
        "totalRevenue": 1521000,
        "debtToEquity": 45.292,
        "revenuePerShare": 0.214,
        "returnOnAssets": -0.33148,
        "grossProfits": -5030000,
        "freeCashflow": -22809124,
        "operatingCashflow": -30922000,
        "revenueGrowth": -0.728,
        "grossMargins": 0,
        "ebitdaMargins": 0,
        "operatingMargins": -21.0217,
        "profitMargins": 31.112429,
        "financialCurrency": "USD"
    }
}